nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—SLCO1A2—Chlorambucil—testicular cancer	0.138	0.165	CbGbCtD
Lovastatin—UGT2B7—Epirubicin—testicular cancer	0.0755	0.0904	CbGbCtD
Lovastatin—UGT1A1—Etoposide—testicular cancer	0.0508	0.0608	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.0432	0.0517	CbGbCtD
Lovastatin—CYP3A7—Ifosfamide—testicular cancer	0.0432	0.0517	CbGbCtD
Lovastatin—ABCC2—Carboplatin—testicular cancer	0.0368	0.0441	CbGbCtD
Lovastatin—ABCC2—Vinblastine—testicular cancer	0.0343	0.0411	CbGbCtD
Lovastatin—CYP3A5—Ifosfamide—testicular cancer	0.0324	0.0388	CbGbCtD
Lovastatin—ABCC2—Cisplatin—testicular cancer	0.0315	0.0377	CbGbCtD
Lovastatin—CYP2C8—Ifosfamide—testicular cancer	0.0312	0.0373	CbGbCtD
Lovastatin—ABCC2—Etoposide—testicular cancer	0.0309	0.037	CbGbCtD
Lovastatin—CYP2C19—Ifosfamide—testicular cancer	0.0261	0.0313	CbGbCtD
Lovastatin—SLCO1A2—Methotrexate—testicular cancer	0.0246	0.0295	CbGbCtD
Lovastatin—SLCO1B1—Methotrexate—testicular cancer	0.0232	0.0278	CbGbCtD
Lovastatin—CYP2C9—Ifosfamide—testicular cancer	0.0217	0.026	CbGbCtD
Lovastatin—ABCC2—Doxorubicin—testicular cancer	0.0211	0.0252	CbGbCtD
Lovastatin—ABCC2—Methotrexate—testicular cancer	0.0204	0.0245	CbGbCtD
Lovastatin—ABCB1—Dactinomycin—testicular cancer	0.0179	0.0214	CbGbCtD
Lovastatin—CYP3A5—Etoposide—testicular cancer	0.0155	0.0185	CbGbCtD
Lovastatin—CYP2C8—Etoposide—testicular cancer	0.0149	0.0178	CbGbCtD
Lovastatin—CYP3A4—Ifosfamide—testicular cancer	0.0126	0.0151	CbGbCtD
Lovastatin—ABCB1—Vinblastine—testicular cancer	0.0112	0.0134	CbGbCtD
Lovastatin—CYP2C9—Cisplatin—testicular cancer	0.0106	0.0127	CbGbCtD
Lovastatin—CYP2D6—Vinblastine—testicular cancer	0.0105	0.0126	CbGbCtD
Lovastatin—ABCB1—Cisplatin—testicular cancer	0.0103	0.0123	CbGbCtD
Lovastatin—ABCB1—Etoposide—testicular cancer	0.0101	0.0121	CbGbCtD
Lovastatin—ABCB1—Doxorubicin—testicular cancer	0.00687	0.00823	CbGbCtD
Lovastatin—CYP3A4—Vinblastine—testicular cancer	0.0067	0.00803	CbGbCtD
Lovastatin—ABCB1—Methotrexate—testicular cancer	0.00666	0.00797	CbGbCtD
Lovastatin—CYP2D6—Doxorubicin—testicular cancer	0.00648	0.00776	CbGbCtD
Lovastatin—CYP3A4—Etoposide—testicular cancer	0.00604	0.00723	CbGbCtD
Lovastatin—PON3—seminal vesicle—testicular cancer	0.00417	0.132	CbGeAlD
Lovastatin—CYP3A4—Doxorubicin—testicular cancer	0.00412	0.00493	CbGbCtD
Lovastatin—HDAC2—Teniposide—Etoposide—testicular cancer	0.00273	1	CbGdCrCtD
Lovastatin—ITGAL—female gonad—testicular cancer	0.0025	0.0793	CbGeAlD
Lovastatin—PON3—female gonad—testicular cancer	0.00245	0.0777	CbGeAlD
Lovastatin—ITGAL—testis—testicular cancer	0.00222	0.0703	CbGeAlD
Lovastatin—PON3—testis—testicular cancer	0.00217	0.0689	CbGeAlD
Lovastatin—HDAC2—embryo—testicular cancer	0.00181	0.0574	CbGeAlD
Lovastatin—ITGAL—lymph node—testicular cancer	0.00161	0.051	CbGeAlD
Lovastatin—HMGCR—seminal vesicle—testicular cancer	0.00154	0.0487	CbGeAlD
Lovastatin—HDAC2—gonad—testicular cancer	0.00123	0.039	CbGeAlD
Lovastatin—HMGCR—gonad—testicular cancer	0.00111	0.0352	CbGeAlD
Lovastatin—UGT2B7—testis—testicular cancer	0.00108	0.0343	CbGeAlD
Lovastatin—HDAC2—female gonad—testicular cancer	0.000999	0.0317	CbGeAlD
Lovastatin—HMGCR—female gonad—testicular cancer	0.000902	0.0286	CbGeAlD
Lovastatin—HDAC2—testis—testicular cancer	0.000886	0.0281	CbGeAlD
Lovastatin—HMGCR—testis—testicular cancer	0.0008	0.0254	CbGeAlD
Lovastatin—HDAC2—lymph node—testicular cancer	0.000642	0.0204	CbGeAlD
Lovastatin—SLCO1A2—testis—testicular cancer	0.000623	0.0198	CbGeAlD
Lovastatin—ABCC2—testis—testicular cancer	0.000581	0.0184	CbGeAlD
Lovastatin—HMGCR—lymph node—testicular cancer	0.00058	0.0184	CbGeAlD
Lovastatin—CYP3A5—female gonad—testicular cancer	0.000443	0.0141	CbGeAlD
Lovastatin—CYP2C8—testis—testicular cancer	0.000436	0.0138	CbGeAlD
Lovastatin—ABCB1—embryo—testicular cancer	0.000427	0.0135	CbGeAlD
Lovastatin—ABCC2—lymph node—testicular cancer	0.000421	0.0133	CbGeAlD
Lovastatin—ABCB1—seminal vesicle—testicular cancer	0.000401	0.0127	CbGeAlD
Lovastatin—CYP2D6—female gonad—testicular cancer	0.000327	0.0104	CbGeAlD
Lovastatin—CYP2D6—testis—testicular cancer	0.00029	0.00921	CbGeAlD
Lovastatin—ABCB1—gonad—testicular cancer	0.00029	0.00919	CbGeAlD
Lovastatin—Decreased appetite—Ifosfamide—testicular cancer	0.000265	0.00203	CcSEcCtD
Lovastatin—Headache—Vinblastine—testicular cancer	0.000265	0.00203	CcSEcCtD
Lovastatin—Toxic epidermal necrolysis—Methotrexate—testicular cancer	0.000265	0.00203	CcSEcCtD
Lovastatin—Leukopenia—Etoposide—testicular cancer	0.000264	0.00203	CcSEcCtD
Lovastatin—Purpura—Doxorubicin—testicular cancer	0.000264	0.00202	CcSEcCtD
Lovastatin—Abdominal pain—Dactinomycin—testicular cancer	0.000263	0.00202	CcSEcCtD
Lovastatin—Body temperature increased—Dactinomycin—testicular cancer	0.000263	0.00202	CcSEcCtD
Lovastatin—Fatigue—Ifosfamide—testicular cancer	0.000263	0.00202	CcSEcCtD
Lovastatin—Anaphylactic shock—Cisplatin—testicular cancer	0.000263	0.00202	CcSEcCtD
Lovastatin—Hypersensitivity—Bleomycin—testicular cancer	0.000263	0.00202	CcSEcCtD
Lovastatin—Infection—Cisplatin—testicular cancer	0.000262	0.002	CcSEcCtD
Lovastatin—Constipation—Ifosfamide—testicular cancer	0.000261	0.002	CcSEcCtD
Lovastatin—Pain—Ifosfamide—testicular cancer	0.000261	0.002	CcSEcCtD
Lovastatin—Thrombocytopenia—Cisplatin—testicular cancer	0.000258	0.00198	CcSEcCtD
Lovastatin—Asthenia—Bleomycin—testicular cancer	0.000256	0.00196	CcSEcCtD
Lovastatin—Pain in extremity—Doxorubicin—testicular cancer	0.000254	0.00195	CcSEcCtD
Lovastatin—Pruritus—Bleomycin—testicular cancer	0.000253	0.00194	CcSEcCtD
Lovastatin—Feeling abnormal—Ifosfamide—testicular cancer	0.000252	0.00193	CcSEcCtD
Lovastatin—Chest pain—Etoposide—testicular cancer	0.000252	0.00193	CcSEcCtD
Lovastatin—Eosinophilia—Methotrexate—testicular cancer	0.000251	0.00193	CcSEcCtD
Lovastatin—Nausea—Vinblastine—testicular cancer	0.000251	0.00193	CcSEcCtD
Lovastatin—Anorexia—Cisplatin—testicular cancer	0.000251	0.00192	CcSEcCtD
Lovastatin—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00025	0.00191	CcSEcCtD
Lovastatin—Pancreatitis—Methotrexate—testicular cancer	0.000249	0.00191	CcSEcCtD
Lovastatin—Discomfort—Etoposide—testicular cancer	0.000249	0.00191	CcSEcCtD
Lovastatin—Toxic epidermal necrolysis—Epirubicin—testicular cancer	0.000248	0.0019	CcSEcCtD
Lovastatin—Hypersensitivity—Dactinomycin—testicular cancer	0.000245	0.00188	CcSEcCtD
Lovastatin—Abdominal discomfort—Methotrexate—testicular cancer	0.000244	0.00187	CcSEcCtD
Lovastatin—Confusional state—Etoposide—testicular cancer	0.000243	0.00186	CcSEcCtD
Lovastatin—Urticaria—Ifosfamide—testicular cancer	0.000243	0.00186	CcSEcCtD
Lovastatin—Abdominal pain—Ifosfamide—testicular cancer	0.000241	0.00185	CcSEcCtD
Lovastatin—Body temperature increased—Ifosfamide—testicular cancer	0.000241	0.00185	CcSEcCtD
Lovastatin—Anaphylactic shock—Etoposide—testicular cancer	0.000241	0.00185	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00024	0.00184	CcSEcCtD
Lovastatin—Infection—Etoposide—testicular cancer	0.00024	0.00184	CcSEcCtD
Lovastatin—Asthenia—Dactinomycin—testicular cancer	0.000239	0.00183	CcSEcCtD
Lovastatin—Influenza—Epirubicin—testicular cancer	0.000238	0.00182	CcSEcCtD
Lovastatin—Paraesthesia—Cisplatin—testicular cancer	0.000236	0.00181	CcSEcCtD
Lovastatin—Thrombocytopenia—Etoposide—testicular cancer	0.000236	0.00181	CcSEcCtD
Lovastatin—ABCB1—female gonad—testicular cancer	0.000235	0.00747	CbGeAlD
Lovastatin—Eosinophilia—Epirubicin—testicular cancer	0.000235	0.0018	CcSEcCtD
Lovastatin—Dyspnoea—Cisplatin—testicular cancer	0.000235	0.0018	CcSEcCtD
Lovastatin—Erectile dysfunction—Methotrexate—testicular cancer	0.000234	0.00179	CcSEcCtD
Lovastatin—Pancreatitis—Epirubicin—testicular cancer	0.000233	0.00179	CcSEcCtD
Lovastatin—Photosensitivity reaction—Methotrexate—testicular cancer	0.000232	0.00178	CcSEcCtD
Lovastatin—Anorexia—Etoposide—testicular cancer	0.00023	0.00176	CcSEcCtD
Lovastatin—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.000229	0.00176	CcSEcCtD
Lovastatin—Decreased appetite—Cisplatin—testicular cancer	0.000229	0.00175	CcSEcCtD
Lovastatin—Diarrhoea—Dactinomycin—testicular cancer	0.000228	0.00175	CcSEcCtD
Lovastatin—Vomiting—Bleomycin—testicular cancer	0.000227	0.00174	CcSEcCtD
Lovastatin—Rash—Bleomycin—testicular cancer	0.000225	0.00173	CcSEcCtD
Lovastatin—Pain—Cisplatin—testicular cancer	0.000225	0.00173	CcSEcCtD
Lovastatin—Dermatitis—Bleomycin—testicular cancer	0.000225	0.00173	CcSEcCtD
Lovastatin—Hypersensitivity—Ifosfamide—testicular cancer	0.000225	0.00172	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000225	0.00172	CcSEcCtD
Lovastatin—Influenza—Doxorubicin—testicular cancer	0.00022	0.00169	CcSEcCtD
Lovastatin—Asthenia—Ifosfamide—testicular cancer	0.000219	0.00168	CcSEcCtD
Lovastatin—Eosinophilia—Doxorubicin—testicular cancer	0.000218	0.00167	CcSEcCtD
Lovastatin—Photosensitivity reaction—Epirubicin—testicular cancer	0.000217	0.00166	CcSEcCtD
Lovastatin—Feeling abnormal—Cisplatin—testicular cancer	0.000217	0.00166	CcSEcCtD
Lovastatin—Paraesthesia—Etoposide—testicular cancer	0.000217	0.00166	CcSEcCtD
Lovastatin—Pruritus—Ifosfamide—testicular cancer	0.000216	0.00166	CcSEcCtD
Lovastatin—Pancreatitis—Doxorubicin—testicular cancer	0.000216	0.00165	CcSEcCtD
Lovastatin—Dyspnoea—Etoposide—testicular cancer	0.000215	0.00165	CcSEcCtD
Lovastatin—Nausea—Bleomycin—testicular cancer	0.000212	0.00163	CcSEcCtD
Lovastatin—Vomiting—Dactinomycin—testicular cancer	0.000212	0.00162	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.00021	0.00161	CcSEcCtD
Lovastatin—Rash—Dactinomycin—testicular cancer	0.00021	0.00161	CcSEcCtD
Lovastatin—Decreased appetite—Etoposide—testicular cancer	0.00021	0.00161	CcSEcCtD
Lovastatin—Diarrhoea—Ifosfamide—testicular cancer	0.000209	0.0016	CcSEcCtD
Lovastatin—ABCB1—testis—testicular cancer	0.000209	0.00662	CbGeAlD
Lovastatin—Body temperature increased—Cisplatin—testicular cancer	0.000208	0.0016	CcSEcCtD
Lovastatin—Fatigue—Etoposide—testicular cancer	0.000208	0.00159	CcSEcCtD
Lovastatin—Neuropathy peripheral—Epirubicin—testicular cancer	0.000208	0.00159	CcSEcCtD
Lovastatin—Pain—Etoposide—testicular cancer	0.000206	0.00158	CcSEcCtD
Lovastatin—Constipation—Etoposide—testicular cancer	0.000206	0.00158	CcSEcCtD
Lovastatin—Urinary tract infection—Epirubicin—testicular cancer	0.000206	0.00158	CcSEcCtD
Lovastatin—Hepatitis—Methotrexate—testicular cancer	0.000203	0.00156	CcSEcCtD
Lovastatin—Dizziness—Ifosfamide—testicular cancer	0.000202	0.00155	CcSEcCtD
Lovastatin—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000201	0.00154	CcSEcCtD
Lovastatin—Sinusitis—Epirubicin—testicular cancer	0.000199	0.00152	CcSEcCtD
Lovastatin—Feeling abnormal—Etoposide—testicular cancer	0.000199	0.00152	CcSEcCtD
Lovastatin—Nausea—Dactinomycin—testicular cancer	0.000198	0.00152	CcSEcCtD
Lovastatin—Gastrointestinal pain—Etoposide—testicular cancer	0.000197	0.00151	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000194	0.00149	CcSEcCtD
Lovastatin—Vomiting—Ifosfamide—testicular cancer	0.000194	0.00149	CcSEcCtD
Lovastatin—Hypersensitivity—Cisplatin—testicular cancer	0.000194	0.00149	CcSEcCtD
Lovastatin—Rash—Ifosfamide—testicular cancer	0.000193	0.00148	CcSEcCtD
Lovastatin—Dermatitis—Ifosfamide—testicular cancer	0.000192	0.00147	CcSEcCtD
Lovastatin—Erythema multiforme—Methotrexate—testicular cancer	0.000192	0.00147	CcSEcCtD
Lovastatin—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000192	0.00147	CcSEcCtD
Lovastatin—Urticaria—Etoposide—testicular cancer	0.000192	0.00147	CcSEcCtD
Lovastatin—Abdominal pain—Etoposide—testicular cancer	0.000191	0.00146	CcSEcCtD
Lovastatin—Body temperature increased—Etoposide—testicular cancer	0.000191	0.00146	CcSEcCtD
Lovastatin—Urinary tract infection—Doxorubicin—testicular cancer	0.000191	0.00146	CcSEcCtD
Lovastatin—Hepatitis—Epirubicin—testicular cancer	0.00019	0.00146	CcSEcCtD
Lovastatin—Asthenia—Cisplatin—testicular cancer	0.000189	0.00145	CcSEcCtD
Lovastatin—Sinusitis—Doxorubicin—testicular cancer	0.000184	0.00141	CcSEcCtD
Lovastatin—Chills—Methotrexate—testicular cancer	0.000182	0.0014	CcSEcCtD
Lovastatin—Nausea—Ifosfamide—testicular cancer	0.000181	0.00139	CcSEcCtD
Lovastatin—Diarrhoea—Cisplatin—testicular cancer	0.00018	0.00138	CcSEcCtD
Lovastatin—Erythema multiforme—Epirubicin—testicular cancer	0.00018	0.00138	CcSEcCtD
Lovastatin—Alopecia—Methotrexate—testicular cancer	0.00018	0.00138	CcSEcCtD
Lovastatin—Hypersensitivity—Etoposide—testicular cancer	0.000178	0.00136	CcSEcCtD
Lovastatin—Flushing—Epirubicin—testicular cancer	0.000177	0.00135	CcSEcCtD
Lovastatin—Hepatitis—Doxorubicin—testicular cancer	0.000176	0.00135	CcSEcCtD
Lovastatin—Dysgeusia—Methotrexate—testicular cancer	0.000173	0.00133	CcSEcCtD
Lovastatin—Asthenia—Etoposide—testicular cancer	0.000173	0.00133	CcSEcCtD
Lovastatin—Back pain—Methotrexate—testicular cancer	0.000171	0.00131	CcSEcCtD
Lovastatin—Chills—Epirubicin—testicular cancer	0.000171	0.00131	CcSEcCtD
Lovastatin—Pruritus—Etoposide—testicular cancer	0.000171	0.00131	CcSEcCtD
Lovastatin—Alopecia—Epirubicin—testicular cancer	0.000168	0.00129	CcSEcCtD
Lovastatin—Vomiting—Cisplatin—testicular cancer	0.000167	0.00128	CcSEcCtD
Lovastatin—Vision blurred—Methotrexate—testicular cancer	0.000167	0.00128	CcSEcCtD
Lovastatin—Erythema multiforme—Doxorubicin—testicular cancer	0.000166	0.00128	CcSEcCtD
Lovastatin—Rash—Cisplatin—testicular cancer	0.000166	0.00127	CcSEcCtD
Lovastatin—Dermatitis—Cisplatin—testicular cancer	0.000166	0.00127	CcSEcCtD
Lovastatin—Diarrhoea—Etoposide—testicular cancer	0.000165	0.00126	CcSEcCtD
Lovastatin—Ill-defined disorder—Methotrexate—testicular cancer	0.000164	0.00126	CcSEcCtD
Lovastatin—Flushing—Doxorubicin—testicular cancer	0.000163	0.00125	CcSEcCtD
Lovastatin—Flatulence—Epirubicin—testicular cancer	0.000163	0.00125	CcSEcCtD
Lovastatin—Dysgeusia—Epirubicin—testicular cancer	0.000162	0.00124	CcSEcCtD
Lovastatin—Back pain—Epirubicin—testicular cancer	0.00016	0.00123	CcSEcCtD
Lovastatin—Malaise—Methotrexate—testicular cancer	0.00016	0.00122	CcSEcCtD
Lovastatin—Dizziness—Etoposide—testicular cancer	0.000159	0.00122	CcSEcCtD
Lovastatin—Muscle spasms—Epirubicin—testicular cancer	0.000159	0.00122	CcSEcCtD
Lovastatin—Vertigo—Methotrexate—testicular cancer	0.000159	0.00122	CcSEcCtD
Lovastatin—Leukopenia—Methotrexate—testicular cancer	0.000158	0.00121	CcSEcCtD
Lovastatin—Chills—Doxorubicin—testicular cancer	0.000158	0.00121	CcSEcCtD
Lovastatin—Nausea—Cisplatin—testicular cancer	0.000156	0.0012	CcSEcCtD
Lovastatin—Vision blurred—Epirubicin—testicular cancer	0.000156	0.0012	CcSEcCtD
Lovastatin—Alopecia—Doxorubicin—testicular cancer	0.000156	0.00119	CcSEcCtD
Lovastatin—Ill-defined disorder—Epirubicin—testicular cancer	0.000154	0.00118	CcSEcCtD
Lovastatin—Vomiting—Etoposide—testicular cancer	0.000153	0.00118	CcSEcCtD
Lovastatin—Rash—Etoposide—testicular cancer	0.000152	0.00117	CcSEcCtD
Lovastatin—Dermatitis—Etoposide—testicular cancer	0.000152	0.00116	CcSEcCtD
Lovastatin—ABCB1—lymph node—testicular cancer	0.000151	0.0048	CbGeAlD
Lovastatin—Headache—Etoposide—testicular cancer	0.000151	0.00116	CcSEcCtD
Lovastatin—Flatulence—Doxorubicin—testicular cancer	0.000151	0.00116	CcSEcCtD
Lovastatin—Myalgia—Methotrexate—testicular cancer	0.000151	0.00116	CcSEcCtD
Lovastatin—Chest pain—Methotrexate—testicular cancer	0.000151	0.00116	CcSEcCtD
Lovastatin—Arthralgia—Methotrexate—testicular cancer	0.000151	0.00116	CcSEcCtD
Lovastatin—Dysgeusia—Doxorubicin—testicular cancer	0.00015	0.00115	CcSEcCtD
Lovastatin—Malaise—Epirubicin—testicular cancer	0.000149	0.00114	CcSEcCtD
Lovastatin—Discomfort—Methotrexate—testicular cancer	0.000149	0.00114	CcSEcCtD
Lovastatin—Vertigo—Epirubicin—testicular cancer	0.000149	0.00114	CcSEcCtD
Lovastatin—Leukopenia—Epirubicin—testicular cancer	0.000148	0.00114	CcSEcCtD
Lovastatin—Back pain—Doxorubicin—testicular cancer	0.000148	0.00114	CcSEcCtD
Lovastatin—Muscle spasms—Doxorubicin—testicular cancer	0.000147	0.00113	CcSEcCtD
Lovastatin—Confusional state—Methotrexate—testicular cancer	0.000146	0.00112	CcSEcCtD
Lovastatin—Anaphylactic shock—Methotrexate—testicular cancer	0.000144	0.00111	CcSEcCtD
Lovastatin—Vision blurred—Doxorubicin—testicular cancer	0.000144	0.00111	CcSEcCtD
Lovastatin—Infection—Methotrexate—testicular cancer	0.000144	0.0011	CcSEcCtD
Lovastatin—Nausea—Etoposide—testicular cancer	0.000143	0.0011	CcSEcCtD
Lovastatin—Ill-defined disorder—Doxorubicin—testicular cancer	0.000142	0.00109	CcSEcCtD
Lovastatin—Thrombocytopenia—Methotrexate—testicular cancer	0.000141	0.00108	CcSEcCtD
Lovastatin—Arthralgia—Epirubicin—testicular cancer	0.000141	0.00108	CcSEcCtD
Lovastatin—Chest pain—Epirubicin—testicular cancer	0.000141	0.00108	CcSEcCtD
Lovastatin—Myalgia—Epirubicin—testicular cancer	0.000141	0.00108	CcSEcCtD
Lovastatin—Anxiety—Epirubicin—testicular cancer	0.000141	0.00108	CcSEcCtD
Lovastatin—Discomfort—Epirubicin—testicular cancer	0.000139	0.00107	CcSEcCtD
Lovastatin—Malaise—Doxorubicin—testicular cancer	0.000138	0.00106	CcSEcCtD
Lovastatin—Dry mouth—Epirubicin—testicular cancer	0.000138	0.00106	CcSEcCtD
Lovastatin—Vertigo—Doxorubicin—testicular cancer	0.000138	0.00106	CcSEcCtD
Lovastatin—Anorexia—Methotrexate—testicular cancer	0.000138	0.00106	CcSEcCtD
Lovastatin—Leukopenia—Doxorubicin—testicular cancer	0.000137	0.00105	CcSEcCtD
Lovastatin—Confusional state—Epirubicin—testicular cancer	0.000136	0.00104	CcSEcCtD
Lovastatin—Anaphylactic shock—Epirubicin—testicular cancer	0.000135	0.00104	CcSEcCtD
Lovastatin—Infection—Epirubicin—testicular cancer	0.000134	0.00103	CcSEcCtD
Lovastatin—Thrombocytopenia—Epirubicin—testicular cancer	0.000132	0.00101	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000132	0.00101	CcSEcCtD
Lovastatin—Insomnia—Methotrexate—testicular cancer	0.000131	0.001	CcSEcCtD
Lovastatin—Chest pain—Doxorubicin—testicular cancer	0.00013	0.001	CcSEcCtD
Lovastatin—Myalgia—Doxorubicin—testicular cancer	0.00013	0.001	CcSEcCtD
Lovastatin—Arthralgia—Doxorubicin—testicular cancer	0.00013	0.001	CcSEcCtD
Lovastatin—Anxiety—Doxorubicin—testicular cancer	0.00013	0.000997	CcSEcCtD
Lovastatin—Paraesthesia—Methotrexate—testicular cancer	0.00013	0.000994	CcSEcCtD
Lovastatin—Discomfort—Doxorubicin—testicular cancer	0.000129	0.000988	CcSEcCtD
Lovastatin—Anorexia—Epirubicin—testicular cancer	0.000129	0.000988	CcSEcCtD
Lovastatin—Dyspnoea—Methotrexate—testicular cancer	0.000129	0.000987	CcSEcCtD
Lovastatin—Dry mouth—Doxorubicin—testicular cancer	0.000128	0.000978	CcSEcCtD
Lovastatin—Dyspepsia—Methotrexate—testicular cancer	0.000127	0.000975	CcSEcCtD
Lovastatin—Confusional state—Doxorubicin—testicular cancer	0.000126	0.000967	CcSEcCtD
Lovastatin—Decreased appetite—Methotrexate—testicular cancer	0.000126	0.000963	CcSEcCtD
Lovastatin—Anaphylactic shock—Doxorubicin—testicular cancer	0.000125	0.000959	CcSEcCtD
Lovastatin—Fatigue—Methotrexate—testicular cancer	0.000125	0.000955	CcSEcCtD
Lovastatin—Infection—Doxorubicin—testicular cancer	0.000124	0.000953	CcSEcCtD
Lovastatin—Pain—Methotrexate—testicular cancer	0.000124	0.000947	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000123	0.000944	CcSEcCtD
Lovastatin—Thrombocytopenia—Doxorubicin—testicular cancer	0.000122	0.000939	CcSEcCtD
Lovastatin—Insomnia—Epirubicin—testicular cancer	0.000122	0.000937	CcSEcCtD
Lovastatin—Paraesthesia—Epirubicin—testicular cancer	0.000121	0.00093	CcSEcCtD
Lovastatin—Dyspnoea—Epirubicin—testicular cancer	0.000121	0.000924	CcSEcCtD
Lovastatin—Anorexia—Doxorubicin—testicular cancer	0.000119	0.000914	CcSEcCtD
Lovastatin—Feeling abnormal—Methotrexate—testicular cancer	0.000119	0.000912	CcSEcCtD
Lovastatin—Dyspepsia—Epirubicin—testicular cancer	0.000119	0.000912	CcSEcCtD
Lovastatin—Gastrointestinal pain—Methotrexate—testicular cancer	0.000118	0.000905	CcSEcCtD
Lovastatin—Decreased appetite—Epirubicin—testicular cancer	0.000118	0.000901	CcSEcCtD
Lovastatin—Fatigue—Epirubicin—testicular cancer	0.000117	0.000893	CcSEcCtD
Lovastatin—Pain—Epirubicin—testicular cancer	0.000116	0.000886	CcSEcCtD
Lovastatin—Constipation—Epirubicin—testicular cancer	0.000116	0.000886	CcSEcCtD
Lovastatin—Urticaria—Methotrexate—testicular cancer	0.000115	0.00088	CcSEcCtD
Lovastatin—Abdominal pain—Methotrexate—testicular cancer	0.000114	0.000875	CcSEcCtD
Lovastatin—Body temperature increased—Methotrexate—testicular cancer	0.000114	0.000875	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000114	0.000874	CcSEcCtD
Lovastatin—Insomnia—Doxorubicin—testicular cancer	0.000113	0.000867	CcSEcCtD
Lovastatin—Paraesthesia—Doxorubicin—testicular cancer	0.000112	0.000861	CcSEcCtD
Lovastatin—Dyspnoea—Doxorubicin—testicular cancer	0.000112	0.000855	CcSEcCtD
Lovastatin—Feeling abnormal—Epirubicin—testicular cancer	0.000111	0.000854	CcSEcCtD
Lovastatin—Gastrointestinal pain—Epirubicin—testicular cancer	0.000111	0.000847	CcSEcCtD
Lovastatin—Dyspepsia—Doxorubicin—testicular cancer	0.00011	0.000844	CcSEcCtD
Lovastatin—Decreased appetite—Doxorubicin—testicular cancer	0.000109	0.000833	CcSEcCtD
Lovastatin—Fatigue—Doxorubicin—testicular cancer	0.000108	0.000827	CcSEcCtD
Lovastatin—Urticaria—Epirubicin—testicular cancer	0.000107	0.000823	CcSEcCtD
Lovastatin—Pain—Doxorubicin—testicular cancer	0.000107	0.00082	CcSEcCtD
Lovastatin—Constipation—Doxorubicin—testicular cancer	0.000107	0.00082	CcSEcCtD
Lovastatin—Body temperature increased—Epirubicin—testicular cancer	0.000107	0.000819	CcSEcCtD
Lovastatin—Abdominal pain—Epirubicin—testicular cancer	0.000107	0.000819	CcSEcCtD
Lovastatin—Hypersensitivity—Methotrexate—testicular cancer	0.000106	0.000816	CcSEcCtD
Lovastatin—Asthenia—Methotrexate—testicular cancer	0.000104	0.000794	CcSEcCtD
Lovastatin—Feeling abnormal—Doxorubicin—testicular cancer	0.000103	0.00079	CcSEcCtD
Lovastatin—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000102	0.000784	CcSEcCtD
Lovastatin—Pruritus—Methotrexate—testicular cancer	0.000102	0.000783	CcSEcCtD
Lovastatin—Hypersensitivity—Epirubicin—testicular cancer	9.96e-05	0.000763	CcSEcCtD
Lovastatin—Urticaria—Doxorubicin—testicular cancer	9.94e-05	0.000762	CcSEcCtD
Lovastatin—Body temperature increased—Doxorubicin—testicular cancer	9.89e-05	0.000758	CcSEcCtD
Lovastatin—Abdominal pain—Doxorubicin—testicular cancer	9.89e-05	0.000758	CcSEcCtD
Lovastatin—Diarrhoea—Methotrexate—testicular cancer	9.88e-05	0.000758	CcSEcCtD
Lovastatin—Asthenia—Epirubicin—testicular cancer	9.7e-05	0.000743	CcSEcCtD
Lovastatin—Pruritus—Epirubicin—testicular cancer	9.56e-05	0.000733	CcSEcCtD
Lovastatin—Dizziness—Methotrexate—testicular cancer	9.55e-05	0.000732	CcSEcCtD
Lovastatin—Diarrhoea—Epirubicin—testicular cancer	9.25e-05	0.000709	CcSEcCtD
Lovastatin—Hypersensitivity—Doxorubicin—testicular cancer	9.22e-05	0.000706	CcSEcCtD
Lovastatin—Vomiting—Methotrexate—testicular cancer	9.18e-05	0.000704	CcSEcCtD
Lovastatin—Rash—Methotrexate—testicular cancer	9.11e-05	0.000698	CcSEcCtD
Lovastatin—Dermatitis—Methotrexate—testicular cancer	9.1e-05	0.000697	CcSEcCtD
Lovastatin—Headache—Methotrexate—testicular cancer	9.05e-05	0.000694	CcSEcCtD
Lovastatin—Asthenia—Doxorubicin—testicular cancer	8.97e-05	0.000688	CcSEcCtD
Lovastatin—Dizziness—Epirubicin—testicular cancer	8.94e-05	0.000685	CcSEcCtD
Lovastatin—Pruritus—Doxorubicin—testicular cancer	8.85e-05	0.000678	CcSEcCtD
Lovastatin—Vomiting—Epirubicin—testicular cancer	8.59e-05	0.000659	CcSEcCtD
Lovastatin—Nausea—Methotrexate—testicular cancer	8.58e-05	0.000658	CcSEcCtD
Lovastatin—Diarrhoea—Doxorubicin—testicular cancer	8.56e-05	0.000656	CcSEcCtD
Lovastatin—Rash—Epirubicin—testicular cancer	8.52e-05	0.000653	CcSEcCtD
Lovastatin—Dermatitis—Epirubicin—testicular cancer	8.52e-05	0.000653	CcSEcCtD
Lovastatin—Headache—Epirubicin—testicular cancer	8.47e-05	0.000649	CcSEcCtD
Lovastatin—Dizziness—Doxorubicin—testicular cancer	8.27e-05	0.000634	CcSEcCtD
Lovastatin—Nausea—Epirubicin—testicular cancer	8.03e-05	0.000615	CcSEcCtD
Lovastatin—Vomiting—Doxorubicin—testicular cancer	7.95e-05	0.00061	CcSEcCtD
Lovastatin—Rash—Doxorubicin—testicular cancer	7.89e-05	0.000605	CcSEcCtD
Lovastatin—Dermatitis—Doxorubicin—testicular cancer	7.88e-05	0.000604	CcSEcCtD
Lovastatin—Headache—Doxorubicin—testicular cancer	7.84e-05	0.000601	CcSEcCtD
Lovastatin—Nausea—Doxorubicin—testicular cancer	7.43e-05	0.000569	CcSEcCtD
